Title: Thomas Ramdahl: Innovator in Targeted Alpha-Particle Therapy
Introduction
Thomas Ramdahl is a notable inventor based in Norway. He has made significant contributions to the field of targeted alpha-particle therapy. His work focuses on developing innovative solutions for therapeutic applications using radionuclides.
Latest Patents
Thomas Ramdahl holds a patent titled "Targeted Alpha-Particle Emitting Complexes Comprising 227-Thorium Radionuclide And Hydroxypyridinone Containing Ligand." This invention provides a tissue-targeting complex that includes a tissue targeting moiety, an octadentate hydroxypyridinone-containing ligand, and the ion of an alpha-emitting thorium radionuclide. The invention also outlines therapeutic methods that utilize these complexes, as well as methods for their production and use, including kits and pharmaceutical compositions.
Career Highlights
Thomas Ramdahl is associated with Algeta ASA, a company that specializes in developing innovative cancer therapies. His work at Algeta ASA has been instrumental in advancing the field of targeted therapies.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Thomas Ramdahl's contributions to targeted alpha-particle therapy highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic methods in cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.